Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT06593860

Dysarthria Management for Minor Groups

This study develops and conduct a small-scale clinical trial study in which the linguistic and cultural diversity of the participants is considered. Speech therapy and counseling services are provided to both patients with Parkinson's disease and their caregivers.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

About this study

Attention has been increasingly paid to the "culturally and linguistically diverse (CLD)" communities which typically include dialectal users of English, monolingual and multilingual speakers of minority languages, and bilingual speakers of English and a minority language. However, among these, monolingual speakers of minority languages living in the US have been nearly excluded from dysarthria management. Most of these are first-generation immigrants who are well documented to have limited access to financial and medical services and have poorer health outcomes including communication difficulties. This creates critical health disparities in the field of communication rehabilitation.

This study will (1) examine effects of speech therapy on PD patients' speech acoustics and intelligibility, (2) examine effects of the intervention program on communication participation and well-being of both PD patients and their families. Our primary outcome measures, speech intelligibility and acoustic measures, are hypothesized to show improvements. Acoustic predictors of speech intelligibility are expected to include acoustic vowel space and voice onset time. These hypotheses are based on literature reporting (1) positive changes in speech function after intensive treatment programs focusing on vocal effort and hyperarticulation and (2) language-specific contributors to speech intelligibility in PD. Our secondary outcome measures include (1) communication participation and (2) well-being measures which will be obtained from both PD patients and family members. Based on previous research, the measures are hypothesized to show improved communication participation and well-being in both PD patients and their families following therapy.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Medical diagnosis of PD
  • No history of other neurological disease
  • Native speaker of Korean
  • Age between 25 and 85
  • Diagnosis of dysarthria secondary to PD from an SLP
  • Self-reported typical hearing
  • Access to high-speed internet for therapy sessions

Exclusion criteria

  • A score of 23 or below on the Korean Montreal Cognitive Assessment
  • Evidence of voice-speech disorders not-related to PD
  • Received speech therapy for PD-related problems in the past one year
  • Have no family members to participate in the project.

Treatment and study plan

Remote speech rehabilitation

Behavioral

Two types of intervention will be provided via online to 32 dyads of people with Parkinson's disease: (1) speech therapy (PD patients) and (2) family education/training (PD families). Speech therapy will replicate the dose prescribed by many treatment programs including LSVT LOUD, LSVT ARTIC and Be Clear, consisting of 16 sessions of 50-60 minutes duration delivered over four weeks. Participants will also be set 15 to 20 minutes of daily home practice. Family education/training will take place once a week over 4 weeks.

Primary outcomes

  1. Speech Intelligibility Score on a Visual Analogue Scale

    Time frame: Immediately after and 6 months after treatment

    Speech intelligibility will be estimated using the visual analogue scale method. Listeners will rate the degree to which they understood the speech recordings on a continuous line. The two ends will be labeled, totally unintelligible and completely intelligible, respectively. Higher scores indicate more intelligible.

  2. Vowel Space Area (kHz)

    Time frame: Immediately after and 6 months after treatment

    Two acoustic measures will be measured as Primary Outcome. The first one is the size of vowel space area, which has been frequently reported to correlate with speech intelligibility in people with Parkinson's disease.

  3. Speaking Rate (syl/s)

    Time frame: Immediately after and 6 months after treatment

    The second acoustic measures to be included as Primary Outcome is speaking rate. This will be reported as the number of syllables produced in one second.

Secondary outcomes

  1. Dysarthria Impact Profile (DIP)

    Time frame: Immediately after and 6 months after treatment

    DIP is an assessment tool designed to measure the psychosocial impact of dysarthria on affected individuals. It consists of several sections with statements rated on a five-point scale, ranging from "strongly agree" to "strongly disagree." DIP incorporates positively and negatively worded statements with differing scoring schemes. This will be obtained from people with Parkinson's disease. Higher scores indicate greater impact of dysarthria.

  2. Everyday Communication Measure

    Time frame: Immediately after and 6 months after treatment

    Family members will also be asked to rate five different aspects of the PD participant's everyday communication abilities using Everyday Communication Measures on a scale of 1 (poor) to 7 (very good). Example questions include, "how easy is it to understand the speaker?" and "how often does the speaker initiate conversation with you?". This will be obtained from family members of PD participants. Lower scores indicate greater difficulties of everyday communication.

  3. Quality of Family Life Scale

    Time frame: Immediately after and 6 months after treatment

    The Family Quality of Life Scale (FQOL) is a 25-item instrument used to measure several aspects of families' perceived satisfaction in terms of quality of family life (e.g., family interaction, emotional well-being, physical/material well-being, and disability-related support). It uses a 1(very dissatisfied)-5 (very satisfied) Likert scale. Higher scores indicated a better quality of family life.

  4. Perceived Stress Scale

    Time frame: Immediately after and 6 months after treatment

    The Perceived Stress Scale (PSP) will be used for measuring psychological stress. Among the three versions of the PSS, the Korean version of PSS-10 will be used. It uses a 0 (never)-4 (very often) Likert scale. Higher scores indicate more stress.

Sponsors and collaborators

Lead sponsor

Florida State University

Other

Registry information

Official study title

Toward a Dysarthria Management Model for Linguistically and Culturally Diverse Groups: Foreign Born Immigrants

Important dates

Study start
2024
Primary completion
2027
Study completion
2027
First posted
Sep 19, 2024
Registry last updated
Jun 3, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.